Table of Contents
Drug Targeting with Glycoproteins and other Peptide Carriers: An Overview; D.K.F. Meijer. Sugar Specific Delivery of Drugs, Oligonucleotides, and Genes; M. Monsigny, et al. The Use of MSH Derivatives for Targeting to Melanomas; D.R. Bard, et al. The Immunogenicity of Recombinant Proteins and of 'Magic Bullets' Represents the Main Obstacle for the Effective in vivo Targeting of Biological Response Modifiers (BRMs); A.H. Sehon. Targeting of Drugs to Tumors: The Use of the Plasminogen Activator Inhibitor as a Ligand; J. Jankun. Advances in Diagnosis and Treatment of Neoplasia Using Radioactive Monoclonal Antibodies; A. Maraveyas, A.A. Epenetos. Targeting Transcription Factors to Inhibit Selectively Gene Expression in Particular Cell Types; A.C. Allison, E.M. Eugui. Design, Biological Properties and Delivery of Antisense Oligonucleotides; J.S. Cohen. Liposomes in vivo: Control of Behaviour; G. Gregoriadis. Passive Targeting of Anthracyclines Entrapped in Longcirculating (Stealth) Liposomes in the Treatment of Cancer; T.M. Allen. Liposomal Drug Delivery: Possibilities for Manipulation; G. Storm, et al. 6 additional articles. Index.
and post it to your social network
Most Helpful Customer Reviews
See all customer reviews >